Despite the COVID-19 lockdown, Occuity remain on track to bring the world's first optical handheld pachymeter to market next year. With the technology alrea...

Having retired just 18 months ago following a 27 year career at Apple HQ in Cupertino CA where he had been one of the lead designers of virtually all the ico...

On the 9th April 2020 Occuity received confirmation that the initial rounds of investment in Occuity were approved by HMRC under the Enterprise Investment Sc...

Occuity have secured grant funding from Innovate UK to further enhance and test their novel technology for monitoring glucose levels through they eye. The gr...

At a busy investor day held at Occuity's offices in Reading, Occuity were able to demonstrate the rapid progress towards the new handheld optical pachymeter....

An article posted on the Medical News Today website (https://www.medicalnewstoday.com/articles/323185) quoting a 2017 report from the US CDC clearly outlines...

Occuity will be unveiling the world's first non-contacting optical handheld Pachymeter at Optrafair 20/20 at the NEC, Birmingham, UK between the 4th and 6th ...

A scientist who invented pioneering technology in the early 1980s to test the concentration of glucose in blood and other liquids was awarded £2 million comp...

Following the launch of their new handheld pachymeter project and the ongoing design and development work, Occuity have agreed to move their adminstrative, m...